Reynoso Jamie L. 4

4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Jul 16, 2026

AI-generated summary of this filing

Updated Jul 16, 2026

Clover Health (CLOV) CEO Jamie Reynoso Sells 13,119 Shares

What Happened

Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments (CLOV), sold 13,119 shares on July 15, 2026. The weighted-average sale price was $4.67 per share (range $4.67–$4.72), generating roughly $61,266 in proceeds.
This transaction was a sale (not a purchase) and was executed as a "sell-to-cover" to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs), not a discretionary trade.

Key Details

Transaction date: 2026-07-15; weighted-average price reported $4.67 (individual trades $4.67–$4.72).
Shares sold: 13,119; approximate proceeds: $61,266.
Shares owned after transaction: Not specified in the provided filing excerpt.
Footnotes: (1) Sale required to cover tax withholding on 6.25% of RSUs that vested July 15, 2026; RSUs were granted Oct 15, 2024, and remaining RSUs vest quarterly through Oct 15, 2028. (2) Price is a weighted average; details of per-trade prices available on request.
Filing timeliness: Form filed on 2026-07-16 for a 2026-07-15 transaction (filed promptly; no late filing indicated).

Context

"Sell-to-cover" transactions are routine tax-related sales when stock awards vest; they do not necessarily indicate the insider's view on the company. This sale represents withholding for RSU vesting rather than a discretionary cash-raising sale.

Form 4

Period: 2026-07-15

CEO, Medicare Advantage

Transactions

Sale
Class A Common Stock
[F1][F2]
2026-07-15$4.67/sh−13,119$61,266→ 2,819,479 total

Footnotes (2)

[F1]The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
[F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Signature

/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso|2026-07-16

1 file